Previous studies have shown that neurodegeneration in HIV infection is accompanied by damage to synaptic terminals  and that synaptic injury might be an early event which may precede neuronal cell loss. For this purpose synaptophysin immunoreactivity was evaluated in the frontal lobes of the same control and infected macaques using paraffin embedded material and computer aided microdensitometry. The results are shown in Fig 3b. A clear trend (P < 0.08) of decreased (approximately 20%) synaptophysin immunoreactivity was observed at 14 days. Statistically significant differences in synaptophysin immunoreactivity were observed in chronically infected macaques with an approximate 30% decrease (P < 0.005). These data demonstrate that, in the SIV–macaque model, injury to the synaptic terminals might be an early pathogenic event.
Finally, to determine if the neuronal damage in the brains of SIV-infected macaques was associated with reactive astrogliosis, patterns and levels of GFAP immunoreactivity were investigated in paraffin embedded tissue using optical densitometry. Compared to controls (Fig. 2d), at 14 days post-SIV infection the frontal cortex of the macaque showed the presence of abundant hypertrophied protoplasmic GFAP immunoreactive astroglial cells (Fig. 2e). At 2 years post-infection abundant fibrillary astroglial cells were observed (Fig. 2f). The results of the densitometric analysis are shown in Fig. 3c. A twofold increase in GFAP immunoreactivity with respect to controls was demonstrated in both the 14 day post-infection animals (P < 0.00005), and those animals chronically infected with SIV (P < 0.001). A previous study also found increased GFAP immunoreactivity in the cortex of SIV-infected macaques suffering from cognitive and/or motor impairment – a condition with onset long after infection . In contrast, this study finds a large increase in GFAP immunoreactivity almost immediately after infection. We conclude that SIV infection causes activation of astrocytes very shortly after systemic infection with SIV, and that this astrogliosis persists in chronically infected animals.
The SIV-infected macaque is an excellent animal model for studying the pathogenesis of HIV infection in general and the neuropathogenesis of HIV infection in particular. Although neuronal injury has not been studied extensively in the SIV–macaque model, neuronal loss in the hippocampus has been reported in one limited study . SIV is the closest known relative of HIV and, like HIV, it infects CD4 macrophages, lymphocytes and microglia. Most importantly, systemic infection with HIV and SIV result in similar neuropathology [39,45,46]. Notably, neuroinvasion occurs early in infection for both HIV [23,24] and in the SIV–macaque model of AIDS [25,26]. However, the relationship between acute neuroinvasion and cellular injury in the brain has not been established.
The decreases in NAA, calbindin, and synaptophysin immunoreactivity observed 2 weeks after SIV infection corresponds to a period of peak viremia, neuroinvasion, increased numbers of perivascular macrophages, and elevation of quinolinic acid [25–31]. The changes we have observed probably reflect a response to these events. Subsequently, as the host mounts an immune response, there is a decrease in viral load and a temporary reversal of these abnormalities. It is possible that changes in NAA, calbindin and synaptophysin may follow a similar course, and thus, may represent reversible neuronal injury.
Our finding here of a progression in the loss of neuronal and synaptic markers in the SIV-infected macaque at an average of 2 years after systemic SIV infection attests to the significant neuronal injury sustained in this model. Of note, we further observed that NAA and calbindin were reduced whether or not the brain exhibited evidence of classic SIVE. This finding corroborates reports of neuronal loss in human brain in the absence of HIV encephalitis [5–12] and points to indirect mechanisms as the cause of brain injury after infection with HIV or SIV. It is important to point out, however, that this does not imply that the virus is not necessary as in the SIV-infected macaque the virus can be detected in almost all infected animals using highly sensitive methods such as in situ hybridization and PCR.
The striking elevation of GFAP that was observed in the macaque 14 days after SIV infection indicates a substantive reaction by the brain to the early neuroinvasion by the virus. Increased expression of GFAP is the hallmark of reactive gliosis, which occurs in response to virtually any damage or disturbance to the CNS. Gliosis is the most frequent reaction to brain insult occurring in a variety of diseases including viral infections, infarction, trauma, spongiform encephalopathies, and neurodegenerative diseases. GFAP elevation and gliosis is commonly observed in the late stages of HIV infection. Notably, early GFAP elevation has been suggested in the rare autopsy studies in acutely HIV-infected people who died of other causes [47,48]. The role of astrogliosis in the pathogenesis HIV related cognitive disorders is unknown but may be important, and may be explored further with the SIV–macaque model.
Neuroinvasion has been found as early as 14 days after infection in the SIV–macaque model and in rare cases among HIV-infected humans. CNS damage occurs subsequently, but before the onset of cognitive deficits. These studies show that damage can be found as early as 14 days after infection and appear to be progressive.
A relationship between acute and chronic brain injury is likely, although this requires further investigation. Even if the early brain injury represents reversible injury, it is plausible that the underlying neurotoxic mechanisms are similar for both early and late injury. If this can be demonstrated, then the acutely infected macaque may be ideal for the study of the pathogenesis of the late motor and cognitive manifestations of HIV infection.
Our findings are especially relevant to recent physiological studies of the SIV–macaque model. It has been reported that macaques demonstrated disruptions in circadian rhythm, reductions of motor activity and changes in auditory-evoked potential latencies in the weeks following infection with SIV . Most of these physiological abnormalities were reversible. The injury to neurons that we report here may explain these abnormalities.
The magnitude of changes in NAA that we have measured suggests that MRS may be used to observe this phenomenon in vivo. If our observations of an early decrease in NAA in unprocessed macaque brain at 2 weeks post-SIV infection are confirmed in vivo, the macaque model may be used to test hypotheses related to the various proposed mechanisms of neuronal injury directly. In vivo studies are currently underway in our laboratory. Furthermore, this model may be used with MRS to test pharmacotherapies to prevent or reverse neuronal injury that may produce the neurocognitive abnormalities resulting from HIV infection in humans, especially if it can be demonstrated that the early neuronal effects we have observed are related to late neuronal injury.
The authors wish to thank Ms. Joane Fordham for help in the preparation of this manuscript.
1. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I.
Ann Neurol 1986, 19: 517 –524.
2. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II.
Ann Neurol 1986, 19: 525 –535.
3. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex.
Science 1988, 239: 586 –592.
4. Price RW, Perry SW. HIV, AIDS, and the Brain.
New York: Raven Press; 1994.
5. Ketzler S, Weis S, Haug H, Budka H. Loss of neurons in the frontal cortex in AIDS brains.
Acta Neuropathol 1990, 80: 92 –94.
6. Wiley CA, Masliah E, Morey M. et al
. Neocortical damage during HIV infection.
Ann Neurol 1991, 29: 651 –657.
7. Everall IP, Luthert PJ, Lantos PL. Neuronal loss in the frontal cortex in HIV infection.
Lancet 1991, 337: 1119 –1121.
8. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA. Spectrum of human immunodeficiency virus-associated neocortical damage.
Ann Neurol 1992, 32: 321 –329.
9. Masliah E, Ge N, Morey M, DeTeresa R, Terry RD, Wiley CA. Cortical dendritic pathology in human immunodeficiency virus encephalitis.
Lab Invest 1992, 66: 285 –291.
10. Everall I, Luthert P, Lantos P. A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia.
J Neuropathol Exp Neurol 1993, 52: 561 –566.
11. Achim CL, Wang R, Miners DK, Wiley CA. Brain viral burden in HIV infection.
J Neuropathol Exp Neurol 1994, 53: 284 –294.
12. Wiley CA, Achim C. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome.
Ann Neurol 1994, 36: 673 –676.
13. Menon DK, Baudouin CJ, Tomlinson D, Hoyle C. Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging.
J Comput Assist Tomogr 1990, 14: 882 –885.
14. Menon DK, Ainsworth JG, Cox IJ. et al
. Proton MR spectroscopy of the brain in AIDS dementia complex.
J Comput Assist Tomogr 1992, 16: 538 –542.
15. Jarvik JG, Lenkinski RE, Grossman RI, Gomori JM, Schnall MD, Frank I. Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation.
Radiology 1993, 186: 739 –744.
16. Meyerhoff DJ, MacKay S, Poole N, Dillon WP, Weiner MW, Fein G. N-acetylaspartate reductions measured by 1H MRSI in cognitively impaired HIV-seropositive individuals.
Magn Reson Imaging 1994, 12: 653 –659.
17. Meyerhoff DJ, MacKay S, Bachman L. et al
. Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging.
Neurology 1993, 43: 509 –515.
18. Chong WK, Sweeney B, Wilkinson ID. et al
. Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings.
Radiology 1993, 188: 119 –124.
19. Chong WK, Paley M, Wilkinson ID. et al
. Localized cerebral proton MR spectroscopy in HIV infection and AIDS.
Am J Neuroradiol 1994, 15: 21 –25.
20. Tracey I, Carr CA, Guimaraes AR, Worth JL, Navia BA, Gonzalez RG. Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: A proton magnetic resonance spectroscopic study.
Neurology 1996, 46: 783 –788.
21. Laubenberger J, Haussinger D, Bayer S. et al
. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times.
Radiology 1996, 199: 805 –810.
22. Bagasra O, Lavi E, Bobroski L. et al
. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry.
AIDS 1996, 10: 573 –585.
23. Johnson RT, McArthur JC, Narayan O. The neurobiology of human immunodeficiency virus infections.
FASEB J 1988, 2: 2970 –2981.
24. Davis LE, Hjelle BL, Miller VE. et al
. Early viral brain invasion in iatrogenic human immunodeficiency virus infection.
Neurology 1992, 42: 1736 –1739.
25. Chakrabarti L, Hurtrel M, Maire MA. et al
. Early viral replication in the brain of SIV-infected rhesus monkeys.
Am J Pathol 1991, 139: 1273 –1280.
26. Lackner AA, Vogel P, Ramos RA, Kluge JD, Marthas M. Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus.
Am J Pathol 1994, 145: 428 –439.
27. Sasseville VG, Newman WA, Lackner AA. et al
. Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus.
Am J Pathol 1992, 141: 1021 –1030.
28. Lackner AA. Pathology of Simian Immunodeficiency Virus Induced Disease.
Berlin: Springer Verlag; 1994.
29. Sasseville VG, Lane JH, Walsh D, Ringler DJ, Lackner AA. VCAM-1 expression and leukocyte trafficking to the CNS occur early in infection with pathogenic isolates of SIV.
J Med Primatol 1995, 24: 123 –131.
30. Smith MO, Heyes MP, Lackner AA. Early intrathecal events in rhesus macaques (Macaca mulatta) infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus.
Lab Invest 1995, 72: 547 –558.
31. Lane JH, Sasseville VG, Smith MO. et al
. Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/microglia and intrathecal immune activation.
J Neurovirol 1996, 2: 423 –432.
32. Desrosiers RC. The simian immunodeficiency viruses.
Annu Rev Immunol 1990, 8: 557 –578.
33. Westmoreland SV, Halpern E, Lackner AA. Simian immunodeficiency virus encephalitis in rhesus macaques is associated with rapid disease progression.
J Neurovirol 1998, 4: 260 –268.
34. Meyerhoff DJ, Bloomer C, Cardenas V, Norman D, Weiner MW, Fein G. Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients.
Neurology 1999, 52: 995 –1003.
35. Chang L, Ernst T, Leonido-Yee M, Walot I, Singer E. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex.
Neurology 1999, 52: 100 –108.
36. Barker PB, Lee RR, McArthur JC. AIDS dementia complex: evaluation with proton MR spectroscopic imaging.
Radiology 1995, 195: 58 –64.
37. Masliah E, Terry RD, Alford M, DeTeresa R. Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections.
J Histochem Cytochem 1990, 38: 837 –844.
38. Masliah E, Ge N, Achim CL, Wiley CA. Differential vulnerability of calbindin-immunoreactive neurons in HIV encephalitis.
J Neuropathol Exp Neurol 1995, 54: 350 –357.
39. Simon MA, Chalifoux LV, Ringler DJ. Pathologic features of SIV-induced disease and the association of macrophage infection with disease evolution.
AIDS Res Hum Retroviruses 1992, 8: 327 –337.
40. Tracey I, Lane J, Chang I, Navia B, Lackner A, Gonzalez RG. 1H magnetic resonance spectroscopy reveals neuronal injury in a simian immunodeficiency virus macaque model.
J Acquir Immune Defic Syndr Hum Retrovirol 1997, 15: 21 –27.
41. Cheng LL, Ma MJ, Becerra L. et al
. Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy.
Proc Natl Acad Sci USA 1997, 94: 6408 –6413.
42. Everall IP, Heaton RK, Marcotte TD. et al
. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder.
:HNRC Group. HIV Neurobehavioral Research Center.
Brain Pathol 1999, 9: 209 –217.
43. Weihe E, Nohr D, Sharer L, Murray E, Rausch D, Eiden L. Cortical astrocytosis in juvenile rhesus monkeys infected with simian immunodeficiency virus.
NeuroReport 1993, 4: 263 –266.
44. Luthert PJ, Montgomery MM, Dean AF, Cook RW, Baskerville A, Lantos PL. Hippocampal neuronal atrophy occurs in rhesus macaques following infection with simian immunodeficiency virus.
Neuropathol Appl Neurobiol 1995, 21: 529 –534.
45. Murray EA, Rausch DM, Lendvay J, Sharer LR, Eiden LE. Cognitive and motor impairments associated with SIV infection in rhesus monkeys.
Science 1992, 255: 1246 –1249.
46. Zink MC, Amedee AM, Mankowski JL. et al
. Pathogenesis of SIV encephalitis.
:Selection and replication of neurovirulent SIV.
Am J Pathol 1997, 151: 793 –803.
47. Eng LF, Ghirnikar RS. GFAP and astrogliosis.
Brain Pathol 1994, 4: 229 –237.
48. Gray F, Scaravilli F, Everall I. et al
. Neuropathology of early HIV-1 infection.
Brain Pathol 1996, 6: 1 –15.
49. Arnold DL, Riess GT, Matthews PM. et al
. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.
Ann Neurol 1994, 36: 76 –82.
50. Barker PB, Gillard JH, van Zijl PC. et al
. Acute stroke: evaluation with serial proton MR spectroscopic imaging.
Radiology 1994, 192: 723 –732.
51. Meyerhoff DJ, MacKay S, Constans JM. et al
. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
Ann Neurol 1994, 36: 40 –47.
52. Shonk TK, Moats RA, Gifford P. et al
. Probable Alzheimer disease: diagnosis with proton MR spectroscopy.
Radiology 1995, 195: 65 –72.
53. Grant I, Atkinson JH, Hesselink JR, et al. Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging
[published erratum appears in Ann Intern Med
:496]. Ann Intern Med
54. Horn TF, Huitron-Resendiz S, Weed MR, Henriksen SJ, Fox HS. Early physiological abnormalities after simian immunodeficiency virus infection.
Proc Natl Acad Sci USA 1998, 95: 15072 –15077.